Watch Ticker

Vor Biopharma Inc. Common Stock

Go to Vor Biopharma Inc. Common Stock Website

$2.11

-0.07 (-3.21%)

Live

Previous Close

$2.09

Day Range

$2.05 - $2.2

Previous Day Range

$2.13 - $2.27

Market Cap

$272.4 million USD

Day Vol.

1.7 million

Previous Day Vol.

1.9 million

Currency

USD

Primary Exchange

Nasdaq

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Sarah Spencer - Vor Bio Announces $175 Million Private Placement

Vor Bio has entered into a securities purchase agreement for a private placement financing expected to raise approximately $175 million through the issuance of prefunded warrants, with participation from several investment firms.

Related tickers: VOR.

Read Full Article

N/A - Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Erez Kalir, a life sciences and technology investor and entrepreneur, to its Board of Directors. Kalir's extensive experience in the biotech sector and track record of fostering innovation will be valuable as Vor Bio continues to execute its strategic vision.

Related tickers: VOR.

Read Full Article

Trending Tickers

Please sign in to view